Amended and Restated Executive Employment AgreementExecutive Employment Agreement • August 9th, 2010 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
ARIAD Pharmaceuticals, Inc. (the "Company") a Delaware corporation, and Edward M. Fitzgerald (the "Employee") enter into the following Amended and Restated Executive Employment Agreement as of the lst day of May, 2010 (hereafter, the “Agreement”).
AND EXCLUSIVE LICENSE AGREEMENTAnd Exclusive License Agreement • August 9th, 2010 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
This AMENDED AND RESTATED COLLABORATION AND EXCLUSIVE LICENSE AGREEMENT (this “Agreement”) is entered into as of May 4, 2010 (the “Restated Effective Date”), by and among ARIAD Pharmaceuticals, Inc. a Delaware corporation with offices at 26 Landsdowne Street, Cambridge, Massachusetts 02139 (“ARIAD”), and Merck Sharp & Dohme Corp. (formerly known as Merck & Co., Inc.), a Corporation organized under the laws of New Jersey with offices at One Merck Drive, Whitehouse Station, NJ 08889-0100 (“MERCK”). Each of MERCK and ARIAD is sometimes referred to individually herein as a “Party” and collectively as the “Parties.”
Amended and Restated Executive Employment AgreementEmployment Agreement • August 9th, 2010 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
ARIAD Pharmaceuticals, Inc. (the "Company") a Delaware corporation, and Pierre Dodion, M.D. (the "Employee") enter into the following Amended and Restated Executive Employment Agreement as of the lst day of May, 2010 (hereafter, the “Agreement”).
